Search Login Register

Sumatriptan (Imigran) Summary

Description: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.

Also Known As: Imigran; 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide; GR-43175; GSK Brand of Sumatriptan; Glaxo Wellcome Brand of Sumatriptan Show All >>

Networked: 1306 relevant articles (339 outcomes, 356 trials/studies) for this Drug

Key Diseases for which Sumatriptan is Relevant

  1. Migraine Disorders (Migraine) : 244 outcomes 277 studies in 927 results
  2. Headache (Headaches) : 84 outcomes 68 studies in 384 results
  3. Pain (Aches) : 54 outcomes 58 studies in 232 results
  4. Cluster Headache (Cluster Headaches) : 27 outcomes 19 studies in 94 results
  5. Nausea : 27 outcomes 16 studies in 86 results
Show All >>

Drugs Related to Sumatriptan

  1. Tablets
  2. Naproxen (Naprosyn)
  3. Ergotamine (Ergotamine Tartrate)
  4. Caffeine (No Doz)
  5. Serotonin (5 Hydroxytryptamine)
  6. Tryptamines (Triptans)
  7. rizatriptan (Maxalt)
  8. Aspirin (Acetylsalicylic Acid)
  9. zolmitriptan (Zomig)
  10. almotriptan (Axert)
Show All >>

Therapies Related to Sumatriptan

  1. Subcutaneous Injections
  2. Oral Administration
  3. Intranasal Administration
  4. Aftercare (After-Treatment)
  5. Emergency Treatment
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.